Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Thermogenesis holdings, inc. crawled time : 13:00 save search
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-06 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -2.5%
H: 2.56%
C: 0.85%
conference global
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
Published: 2023-05-10 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -2.01%
H: 5.13%
C: 2.05%
update financial results
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
Published: 2023-03-28 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -2.81%
H: 0.0%
C: -13.11%
year update financial results
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
Published: 2023-03-16 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 7.4%
H: 38.44%
C: 33.33%
nasdaq
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies
Published: 2023-03-15 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 98.1%
H: 26.07%
C: 0.24%
companies therapy
ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -1.28%
H: 9.09%
C: -0.16%
global conference
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide a Corporate Strategic Update
Published: 2022-05-18 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -1.79%
H: 10.52%
C: 2.72%
CGT CDMO: Controlled Cell Manufacturing Meets Controlled Smart Storage Solutions
Published: 2021-12-08 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 4.17%
H: 0.0%
C: -1.6%
BACS: What to Consider When Sorting Cell Populations
Published: 2021-11-18 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: -9.33%
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update
Published: 2021-11-05 (Crawled : 13:00) - biospace.com/
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -1.23%
H: 5.0%
C: 0.0%
financial results results
The Importance of Trust in a Cell and Gene Therapy (CGT) CDMO Relationship
Published: 2021-11-04 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 1.25%
H: 1.23%
C: 0.0%
gene therapy therapy cel
CDMO: The Importance of Closed Systems in the Manufacturing Process
Published: 2021-10-27 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -0.63%
H: 1.57%
C: -5.66%
system
CDMO: The Rise of End-to-End Services
Published: 2021-10-20 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 0.0%
H: 0.25%
C: -0.55%
ThermoGenesis BioArchive System: The Best Smart Storage Solution for the Cell Therapy Manufacturing Process
Published: 2021-09-29 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -1.46%
H: 5.39%
C: -2.46%
therapy hiv
Employee Spotlight: Getting to Know Our Designer – Brian Malone
Published: 2021-09-22 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: 0.45%
H: 1.81%
C: -1.36%
designation
Obstacles Preventing GMP Cell Therapy from Becoming Mainstream
Published: 2021-09-15 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -0.87%
H: 0.44%
C: -1.75%
therapy
ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies
Published: 2021-09-14 (Crawled : 13:00) - biospace.com/
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -0.42%
H: 2.51%
C: -2.53%
Cryopreservation: A Key Element in the Successful Delivery of GMP Cell Therapies
Published: 2021-09-09 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -0.84%
H: 4.24%
C: -2.12%
cryo liver therapy
Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-07 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -1.64%
H: 2.08%
C: 0.42%
conference
The Process of Bringing a Clinical Discovery to Market – From Concept to Commercial for Cell and Gene Therapy Products
Published: 2021-09-01 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K
|
Health Technology
|
| O: -5.71%
H: 6.06%
C: 3.46%
gene therapy therapy gene therapies commercialization
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.